NCT06097871

RCT of an Oral Acne Supplement for Adult Women

A Double-Blinded, Randomized Control Evaluation of the Efficacy of an Oral Acne Supplement for Adult Women

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 102 (actual)
• Sponsor: Nutraceutical Wellness Inc. · Industry
• Sex: Female
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

This study is to assess the efficacy and tolerability of an oral supplement in mild to moderate acne in adult females.

Detailed description

This is a 12-week, single-center, placebo controlled double blind, randomized clinical trial in adult female subjects with mild to moderate non-cystic acne. Female subjects will be enrolled in this single site study to evaluate the efficacy of an oral acne supplement. Upon enrollment, subjects will be randomized to a treatment or a placebo group. Both the subject and the investigator will be blinded to the subject's group allocation. The objective of this research is to assess the efficacy and tolerability of an oral supplement in mild to moderate non-cystic acne in adult females when compared to a placebo.

Conditions

• Acne

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Skin Nutraceutical Supplement	The Skin Nutraceutical Supplement is made with Nutrafol's patented Synergen Skin Complex®, which is a blend of proprietary formulation of botanicals with potent anti-inflammatory, anti-stress adaptogenic, antioxidant and DHT-inhibiting properties combined to synergistically combat the multiple underlying factors that compromise skin health. These ingredients include Holy Basil, Maca, Curcumin, and Berberine in combination with other nutrients used to support skin health such as olive extract (20% hydroxytyrosol), konjac root (3% ceramides), vitamin A, B vitamins, and vitamin C.
OTHER	Placebo pill	A placebo pill containing non-active ingredients

Timeline

• Start date: 2024-01-15
• Primary completion: 2024-07-24
• Completion: 2024-07-25
• First posted: 2023-10-24
• Last updated: 2024-09-25

Locations

1 site across 1 country: United States